Drug Topics
OCTOBER 8, 2024
Florida-based pharmacist Brad Phillips, PharmD, BCACP, speaks to the importance of pre-planning, emergency refills, medication storage, and post-storm safety measures to ensure medication security during hurricanes.
STAT
OCTOBER 8, 2024
On June 17, He Jiankui received an email that wasted no time getting to the point: An American cryptocurrency entrepreneur had learned about the Chinese scientist’s recent proposal to use CRISPR gene-editing technology on human embryos to lower their future risk of developing Alzheimer’s disease, and he was offering funding and other help to turn those plans into a new commercial venture. He rose to international infamy in 2018, when it came to light that he
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 8, 2024
Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.
PharmaVoice
OCTOBER 8, 2024
This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
OCTOBER 8, 2024
A new NIH program will allocate nearly $30 million to 10 groups over five years to examine the impact of ableism on various health outcomes for people with disabilities and to develop strategies to combat these disparities. The studies investigate ableism towards several different populations, including people with low vision trying to access services and maternal health outcomes among Medicaid beneficiaries with intellectual and developmental disabilities.
Pharmacy Times
OCTOBER 8, 2024
Survodutide is a glucagon/glucagon-like peptide-1 (GLP-1_ receptor dual agonist that activates the glucagon and GLP-1 receptors to better control metabolic function.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Pharma
OCTOBER 8, 2024
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, claiming its action to remove Eli Lilly’s Mounjaro and Zepbound from its drug shortage list is a “reckless and arbitrary decision—lacking any semblance of lawful process.” In declaring the end of the shortage, the FDA has halted the ability of compounding pharmacies to manufacture the in-demand products.
STAT
OCTOBER 8, 2024
John Maraganore, the former CEO of Alnylam Pharmaceuticals turned biotech elder statesman and venture capitalist, is launching a new startup that he hopes can expand upon his previous company’s success. His new venture, City Therapeutics, launched Tuesday with $135 million from ARCH Venture Partners, Fidelity, Invus, Rock Springs Capital, Regeneron Ventures, and others, he told STAT exclusively.
Fierce Pharma
OCTOBER 8, 2024
Editor's Note: Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub in Tampa, Florida, in 2021—is setting out to bolster emergency services, pool donations and ease medical supply needs as Hurricane Milton touches down this week.
STAT
OCTOBER 8, 2024
Amid ongoing scrutiny of pharmacy benefit managers, the U.S. Supreme Court has asked the solicitor general to weigh in on an Oklahoma law that seeks to regulate the retail networks created by these controversial middlemen in the pharmaceutical supply chain. The law, which was enacted in 2019, was designed to ensure that pharmacy benefit managers maintain access to a large number of pharmacies and do not steer patients to favored outlets, among other things.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
OCTOBER 8, 2024
Investigators report the study met its primary end point, demonstrating that a single, oral dose reduced the transmission by those infected to others in their household.
pharmaphorum
OCTOBER 8, 2024
Stay updated on the latest insights from EASD 2024 with a comprehensive breakdown of key themes, topics, and influencers. Learn more about the essential information you need to know.
Pharmacy Times
OCTOBER 8, 2024
Vaccine gap closure programs in Missouri and California provide a blueprint for a successful campaign.
Fierce Pharma
OCTOBER 8, 2024
Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a new positive readout can return Keytruda to glory in head and neck cancer about two years after a prior failure.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
OCTOBER 8, 2024
This marks India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed/refractory multiple myeloma.
pharmaphorum
OCTOBER 8, 2024
Collaboration is essential for the future of healthcare, and events play a pivotal role in fostering it. Learn how collaboration can drive innovation in healthcare through impactful events.
Fierce Pharma
OCTOBER 8, 2024
While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case for its first-to-market respiratory syncytial virus (RSV) shot Arexvy. | GSK on Tuesday unveiled fresh data from the late-stage AReSVi-006 study of Arexvy in RSV-triggered lower respiratory tract disease in older adults over the span of three full RSV seasons.
pharmaphorum
OCTOBER 8, 2024
Discover the latest advancements in weight loss treatments as developers race to create the next blockbuster solution. Stay informed about the cutting-edge options available.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
OCTOBER 8, 2024
Substance use disorder continues to be a pervasive health challenge in the U.S. | Carrum Health, a company that established value-based Centers of Excellence for employers, unveiled Tuesday a new value-based treatment model for substance use disorders.
STAT
OCTOBER 8, 2024
LONDON — Two pioneers behind machine learning — a technology that is already transforming society in ways big and small and that carries profound ethical questions — won the Nobel Prize in physics on Tuesday. The award went to John Hopfield, 91, of Princeton University and Geoffrey Hinton, 76, of the University of Toronto, “for foundational discoveries and inventions that enable machine learning with artificial neural networks,” the Nobel committee announced.
pharmaphorum
OCTOBER 8, 2024
How pharma companies can build mutually beneficial relationships with biotech and digital health start-ups Mike.
Fierce Healthcare
OCTOBER 8, 2024
Chronic kidney disease is a silent threat. | This week on "Podnosis," Fierce Healthcare's Emma Beavins chats with Healthy.io CEO Geoff Martin about how his company is helping to address the hidden crisis of chronic kidney disease.
STAT
OCTOBER 8, 2024
Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and middle-income countries, marking the second time in two years the company is taking such steps. But as before, the move was met with criticism over certain details. The latest effort involves tripling the annual supply of the drug, a long-acting medication known as cabotegravir, in hopes of making more than 2 million doses available during 2025 and 2026.
Fierce Healthcare
OCTOBER 8, 2024
Denials by commercial health plans rose 56 percent in 2023. | Health system executives and end users convened with health plan attendees across a variety of disciplines – revenue cycle, utilization management, physician advisor, and case management.
Pharmacy Times
OCTOBER 8, 2024
Women were also more likely to report concerns of high wait times prior to receiving care.
Drug Topics
OCTOBER 8, 2024
The 70-plus-page lawsuit is directed at Express Scripts for its dealings with drug manufacturers in fueling the US opioid crisis.
pharmaphorum
OCTOBER 8, 2024
Takeda's recently approved advanced colorectal cancer therapy Fruzaqla has been rejected by NICE for use by the NHS in draft guidance
Drug Topics
OCTOBER 8, 2024
The Healgen Rapid Check COVID-19/Flu A&B Antigen Test is the first at-home test to be granted marketing authorization using a traditional premarket review pathway.
pharmaphorum
OCTOBER 8, 2024
Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings in early 2025.The stock rocketed 362% after the announcement, taking Scholar Rock's market cap above $2.7 billion, as analysts started to talk about a blockbuster sales opportunity for the selective myostatin inhibitor.
Fierce Healthcare
OCTOBER 8, 2024
One of the key selling points of Medicare Advantage (MA) is the supplemental benefits plans can offer, especially extending coverage for dental, vision and hearing care that the traditional program | A new study published in Health Affairs finds that while these benefits are common in MA, low-income beneficiaries still face significant access barriers to dental, vision and hearing services.
pharmaphorum
OCTOBER 8, 2024
Biogen teams up with Talkiatry on telehealth programme for postpartum depression that could help drive sales of Zurzuvae
PioneerRx
OCTOBER 8, 2024
The devastation caused by natural disasters is often unprecedented, and preparedness is key to mitigating their impact. With climate experts noting an increase.
pharmaphorum
OCTOBER 8, 2024
Astellas adds a gene therapy for frontotemporal dementia to its pipeline, via a $2.2bn+ option deal with UK biotech AviadoBio.
Expert insights. Personalized for you.
220 
Let's personalize your content